Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

DPH 1,018.20 +3.20 (0.32%)
price chart
Analysts Set Dechra Pharmaceuticals plc Target Price at $803.49 (LON:DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) has been given a consensus rating of �Buy� by the three ratings firms that are presently covering the company, Stock Ratings News reports.
Dechra Pharmaceuticals plc Receives GBX 803.49 Average PT from Analysts ...
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) has received a consensus rating of �Buy� from the nine ratings firms that are covering the company, American Banking News.
Dechra Pharmaceuticals plc Earns "Hold" Rating from N+1 Singer (DPH)
Analysts at Edison Investment Research reiterated a no rating system rating and set a GBX 955 ($14.38) price target on shares of Dechra Pharmaceuticals plc in a research note on Friday, February 27th. Analysts at Numis Securities Ltd downgraded shares ...
Recent Research Analysts' Ratings Changes for Dechra Pharmaceuticals plc ...
2/27/2015 - Dechra Pharmaceuticals plc had its �no rating system� rating reaffirmed by analysts at Edison Investment Research.
Dechra Pharmaceuticals plc (DPH) - Investment Analysts' Weekly Ratings Updates
2/27/2015 - Dechra Pharmaceuticals plc had its �no rating system� rating reaffirmed by analysts at Edison Investment Research.
Dechra Pharmaceuticals plc Given "Hold" Rating at N+1 Singer (DPH)  Intercooler
3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and ...
Back in February last year I penned an article titled David & Goliath: AstraZeneca versus Hikma Pharmaceuticals, which compared the prospects of the two firms and suggested that looking down the food chain in the pharmaceutical sector could produce an ...
Dechra Pharmaceuticals plc Given New GBX 950 Price Target at Panmure Gordon  Dakota Financial News
Dechra Pharmaceuticals plc Stock Rating Reaffirmed by N+1 Singer (DPH)
Dechra Pharmaceuticals plc (LON:DPH)'s stock had its �hold� rating reiterated by analysts at N+1 Singer in a research report issued to clients and investors on Friday.
Dechra Pharmaceuticals plc Price Target Raised to GBX 885 at N+1 Singer (DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) had its price target upped by N+1 Singer from GBX 783 ($12.04) to GBX 885 ($13.61) in a research note issued to investors on Monday.
Dechra Pharmaceuticals plc Stock Rating Reaffirmed by FinnCap (DPH)  The Legacy
Dechra Pharmaceuticals plc's "Buy" Rating Reaffirmed at ...  Ticker Report
Dechra Pharmaceuticals plc Given Average Recommendation of "Buy" by ...
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have earned a consensus rating of �Buy� from the nine ratings firms that are currently covering the company, Analyst Ratings News reports.
Investec Reaffirms Buy Rating for Dechra Pharmaceuticals plc (DPH)
Shares of Dechra Pharmaceuticals plc (LON:DPH) opened at 926.00 on Monday. Dechra Pharmaceuticals plc has a one year low of GBX 655.00 and a one year high of GBX 943.00.
Dechra Pharmaceuticals plc (DPH) - Investment Analysts' Recent Ratings ...  sleekmoney
Numis Securities Ltd Lowers Dechra Pharmaceuticals plc to Hold (DPH)  Intercooler